MedTrace Logo

Visual Function Changes After Intraocular Pressure Reduction

NCT00435058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2007-02-19

No results posted yet for this study

Summary

During the glaucomatous disease process, subpopulations of cells may be dead, damaged or healthy. Visual function changes could be observed due to a recovering of the suffering ganglion cells after the intraocular pressure reduction. This study aims at evaluating the correlation between intraocular pressure reduction and visual function changes in glaucoma patients after using antiglaucoma medications.

Conditions

Interventions

DRUG

timolol maleate 0,5%

DRUG

brimonidine tartrate 0,2%

DRUG

travoprost 0,004%

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Tiago Prata, MD · Federal University of São Paulo

  • Luiz A Melo Jr, MD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2006-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00435058 on ClinicalTrials.gov